Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal

Related Experiment Video

Updated: Jun 28, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Guikai Wu1, Xiao-Long Qiu, Longen Zhou

  • 1Department of Biological Chemistry, School of Medicine, University of California, Irvine, California 92697, USA.

Cancer Research
|October 17, 2008
PubMed

Insights

A new compound, INH1, disrupts the Hec1/Nek2 interaction, inhibiting breast cancer cell proliferation and tumor growth. This finding highlights the Hec1/Nek2 pathway as a potential target for novel cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Hec1 is a crucial mitotic regulator implicated in cancer progression.
  • Overexpression of Hec1 correlates with poor prognosis in breast cancer patients.

Purpose of the Study:

  • To identify small molecules targeting the Hec1/Nek2 interaction.
  • To evaluate the therapeutic potential of INH1 in breast cancer models.

Main Methods:

  • Chemical genetic screening to identify INH1.
  • In vitro studies on breast cancer cell lines.
  • In vivo studies using a mouse xenograft model.

Main Results:

  • INH1 directly binds Hec1, disrupting the Hec1/Nek2 interaction.
  • INH1 treatment reduces kinetochore-bound Hec1 and global Nek2 levels.
  • INH1 causes chromosome misalignment, spindle defects, and cell death.
  • INH1 inhibits proliferation of breast cancer cell lines (GI(50) 10-21 µM).
  • INH1 treatment retards tumor growth in vivo without apparent side effects.

Conclusions:

  • The Hec1/Nek2 pathway is a viable target for cancer intervention.
  • INH1 demonstrates therapeutic potential as a novel anti-cancer agent.

More Related Videos

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...